The MUHC ASP committee is happy to announce the update and publication of several guidelines:
Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg
COVID management guidelines (minor changes)
COVID outpatient decision tree : inclusion of situation in which to give Evusheld
Antifungal prophylaxis guidelines (developed with the help of Transplant and Hematology-oncology team)
We are also proud to publish our Annual report for 2021-2022. It is now available in the section Resources of the website.
Good reading to all and happy thanksgiving!
Francois Bourdeau, ASP co-chair